Bionova Scientific Licenses ATUM's Proprietary Transposon-Based Gene Delivery Technology To Accelerate & De-Risk Cell ...
Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line …